论文部分内容阅读
目的评价清肺口服液用于儿童病毒性肺炎的临床疗效和安全性。方法检索中国学术期刊全文数据库、维普、中国生物医学文献数据库、pubmed和Web of Science数据库,收集有关清肺口服液用于儿童病毒性肺炎治疗的临床研究,根据纳入和剔除标准收集文献,进行Meta分析。结果共纳入7篇临床对照研究,meta分析结果显示,清肺口服液组在退热时间、咳嗽治愈率以及总有效率方面均优于对照组。结论清肺口服液治疗儿童病毒性肺炎疗效确切,在退热时间、咳嗽治愈率及整体疗效方面均优于对照组,但纳入研究的方法学质量低,其疗效需更多高质量临床试验来验证。
Objective To evaluate the clinical efficacy and safety of Qingfei Oral Liquid in children with viral pneumonia. Methods The full-text database of Chinese academic journals, VIP, Chinese Biomedical Literature Database, pubmed and Web of Science databases were collected and collected for the clinical research of Qingfei Oral Liquid for the treatment of viral pneumonia in children. According to the inclusion and exclusion criteria, analysis. Results A total of 7 controlled trials were included in the meta-analysis. The results of meta-analysis showed that Qingfei Oral Liquid Group was superior to the control group in terms of antipyretic time, cough cure rate and total effective rate. Conclusion Qingfei oral liquid treatment of children with viral pneumonia curative effect is exact, in the antipyretic time, cough cure rate and the overall efficacy are better than the control group, but the method of study included in the low quality of the curative effect needs more high-quality clinical trials to verification.